Identification of anti-gastric cancer effects and molecular mechanisms of resveratrol: From network pharmacology and bioinformatics to experimental validation

被引:4
|
作者
Ma, Ying-Qian [1 ,2 ]
Zhang, Ming [1 ,5 ]
Sun, Zhen-Hua [1 ]
Tang, Hong-Yue [3 ]
Wang, Ying [2 ]
Liu, Jiang-Xue [2 ]
Zhang, Zhan-Xue [4 ]
Wang, Chao [3 ]
机构
[1] Hebei Gen Hosp, Dept Oncol, Shijiazhuang 050051, Hebei, Peoples R China
[2] Hebei Med Univ, Sch Grad Studies, Shijiazhuang 050017, Hebei, Peoples R China
[3] Hebei Gen Hosp, Clin Med Res Ctr, Shijiazhuang 050051, Hebei, Peoples R China
[4] Hebei Med Univ, Hosp 2, Dept Gastrointestinal Surg, Shijiazhuang 050000, Hebei, Peoples R China
[5] Hebei Gen Hosp, Dept Oncol, 348 Heping West Rd, Shijiazhuang 050051, Hebei, Peoples R China
关键词
Resveratrol; Gastric cancer; Network pharmacology; Bioinformatics; Molecular docking; CELL-CYCLE; C-FOS; PROLIFERATION; INHIBITORS; PROTEIN;
D O I
10.4251/wjgo.v16.i2.493
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND Gastric cancer (GC) is one of the most aggressive malignancies with limited therapeutic options and a poor prognosis. Resveratrol, a non-flavonoid polyphenolic compound found in a variety of Chinese medicinal materials, has shown excellent anti-GC effect. However, its exact mechanisms of action in GC have not been clarified. AIM To identify the effects of resveratrol on GC progression and explore the related molecular mechanisms. METHODS Action targets of resveratrol and GC-related targets were screened from public databases. The overlapping targets between the two were confirmed using a Venn diagram, and a "Resveratrol-Target-GC" network was constructed using Cytoscape software version 3.9.1. The protein-protein interaction (PPI) network was constructed using STRING database and core targets were identified by PPI network analysis. The Database for Annotation, Visualization and Integrated Discovery database was used for Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis. A "Target-Pathway" network was created by using Cytoscape 3.9.1. The RNA and protein expression levels of core target genes were observed using the Cancer Genome Atlas and the Human Protein Atlas databases. DriverDBv3 and Timer2.0 databases were used for survival and immune infiltration analysis. Subsequently, the findings were further verified by molecular docking technology and in vitro experiments. RESULTS A total of 378 resveratrol action targets and 2154 GC disease targets were obtained from public databases, and 181 intersection targets between the two were screened by Venn diagram. The top 20 core targets were identified by PPI network analysis of the overlapping targets. GO function analysis mainly involved protein binding, identical protein binding, cytoplasm, nucleus, negative regulation of apoptotic process and response to xenobiotic stimulus. KEGG enrichment analysis suggested that the involved signaling pathways mainly included PI3K-AKT signaling pathway, MAPK signaling pathway, IL-17 signaling pathway, TNF signaling pathway, ErbB signaling pathway, etc. FBJ murine osteosarcoma viral oncogene homolog (FOS) and matrix metallopeptidase 9 (MMP9) were selected by differential expression analysis, and they were closely associated with immune infiltration. Molecular docking results showed that resveratrol docked well with these two targets. Resveratrol treatment arrested the cell cycle at the S phase, induced apoptosis, and weakened viability, migration and invasion in a dose-dependent manner. Furthermore, resveratrol could exhibit anti-GC effect by regulating FOS and MMP9 expression. CONCLUSION The anti-GC effects of resveratrol are related to the inhibition of cell proliferation, migration, invasion and induction of cell cycle arrest and apoptosis by targeting FOS and MMP9.
引用
收藏
页码:493 / 513
页数:22
相关论文
共 50 条
  • [41] Effects and mechanisms of Zhizi Chuanxiong herb pair against atherosclerosis: an integration of network pharmacology, molecular docking, and experimental validation
    Yan Zhang
    Yifei Qi
    Zijun Jia
    Yiming Li
    Liqi Wu
    Qingbing Zhou
    Fengqin Xu
    Chinese Medicine, 19
  • [42] Effects and mechanisms of Zhizi Chuanxiong herb pair against atherosclerosis: an integration of network pharmacology, molecular docking, and experimental validation
    Zhang, Yan
    Qi, Yifei
    Jia, Zijun
    Li, Yiming
    Wu, Liqi
    Zhou, Qingbing
    Xu, Fengqin
    CHINESE MEDICINE, 2024, 19 (01)
  • [43] Anti cancer molecular mechanism of Actinidia chinensis Planch in gastric cancer based on network pharmacology and molecular docking
    Chen, Yuye
    Zhu, Xiaoyong
    Su, Xiyang
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2022, 21 (12) : 2591 - 2599
  • [44] Molecular Mechanisms of Luteolin Against Atopic Dermatitis Based on Network Pharmacology and in vivo Experimental Validation
    Tang, Liu
    Gao, Jiefang
    Li, Xiaolei
    Cao, Xiaoqin
    Zhou, Benhong
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2022, 16 : 4205 - 4221
  • [45] A network pharmacology-based investigation of the mechanism involved in the anti-gastric cancer effect of Oldenlandia diffusan, a traditional Chinese medicine
    Ma, Zhenchi
    Zhao, Peng
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2022, 21 (11) : 2403 - 2410
  • [46] Exploring the Targets and Molecular Mechanisms of Thalidomide in the Treatment of Ulcerative Colitis: Network Pharmacology and Experimental Validation
    Li, Jun
    Tao, Qin
    Xie, Yang
    Wang, Peng
    Jin, Ruiri
    Huang, Xia
    Chen, Youxiang
    Zeng, Chunyan
    CURRENT PHARMACEUTICAL DESIGN, 2023, 29 (34) : 2721 - 2737
  • [47] Network Pharmacology and Experimental Validation to Explore the Molecular Mechanisms of Compound Huangbai Liquid for the Treatment of Acne
    Di, Huifeng
    Liu, Hui
    Xu, Shuna
    Yi, Na
    Wei, Guangchen
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2023, 17 : 39 - 53
  • [48] Molecular mechanisms of Buqing granule for the treatment of diabetic retinopathy: Network pharmacology analysis and experimental validation
    Yang, Yi-Fan
    Yuan, Ling
    Li, Xiang-Yang
    Liu, Qian
    Jiang, Wen-Jie
    Jiao, Tai-Qiang
    Li, Jia-Qing
    Ye, Meng-Yi
    Niu, Yang
    Nan, Yi
    WORLD JOURNAL OF DIABETES, 2024, 15 (09)
  • [49] Anti-inflammatory effects of resveratrol in treating interstitial cystitis/bladder pain syndrome: a multi-faceted approach integrating network pharmacology, molecular docking, and experimental validation
    Li, Wenshuang
    Luo, Ruixiang
    Liu, Zheng
    Li, Xiaoyang
    Zhang, Chi
    Huang, Junlong
    Wang, Ziqiao
    Chen, Jialiang
    Ding, Honglu
    Zhou, Xiangfu
    Liu, Bolong
    MOLECULAR DIVERSITY, 2024,
  • [50] Potential anti-liver cancer targets and mechanisms of kaempferitrin based on network pharmacology, molecular docking and experimental verification
    Zhou S.
    Zhang H.
    Li J.
    Li W.
    Su M.
    Ren Y.
    Ge F.
    Zhang H.
    Shang H.
    Computers in Biology and Medicine, 2024, 178